RS47804A - 1,3-diarilprop-2-en-1-oni, preparati koji ih sadrže i njihova upotreba - Google Patents
1,3-diarilprop-2-en-1-oni, preparati koji ih sadrže i njihova upotrebaInfo
- Publication number
- RS47804A RS47804A YU47804A YUP47804A RS47804A RS 47804 A RS47804 A RS 47804A YU 47804 A YU47804 A YU 47804A YU P47804 A YUP47804 A YU P47804A RS 47804 A RS47804 A RS 47804A
- Authority
- RS
- Serbia
- Prior art keywords
- propenone
- amino
- methoxy
- methyl
- trimethoxyphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
- C07C279/32—N-nitroguanidines
- C07C279/36—Substituted N-nitroguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Bending Of Plates, Rods, And Pipes (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0115739A FR2833008B1 (fr) | 2001-12-05 | 2001-12-05 | 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation |
| FR0214217 | 2002-11-14 | ||
| PCT/FR2002/004143 WO2003048106A2 (fr) | 2001-12-05 | 2002-12-03 | 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS47804A true RS47804A (sr) | 2006-12-15 |
Family
ID=26213287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU47804A RS47804A (sr) | 2001-12-05 | 2002-12-03 | 1,3-diarilprop-2-en-1-oni, preparati koji ih sadrže i njihova upotreba |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1453790A2 (de) |
| JP (1) | JP2005531494A (de) |
| KR (1) | KR20050044712A (de) |
| CN (1) | CN1612856A (de) |
| AR (1) | AR037479A1 (de) |
| AU (1) | AU2002365644A1 (de) |
| BR (1) | BR0214694A (de) |
| CA (1) | CA2469193A1 (de) |
| CO (1) | CO5580759A2 (de) |
| EA (1) | EA006803B1 (de) |
| HR (1) | HRP20040508A2 (de) |
| HU (1) | HUP0500100A2 (de) |
| IL (1) | IL162223A0 (de) |
| MA (1) | MA27351A1 (de) |
| MX (1) | MXPA04005226A (de) |
| NZ (1) | NZ533224A (de) |
| PA (1) | PA8558501A1 (de) |
| PE (1) | PE20030758A1 (de) |
| PL (1) | PL370676A1 (de) |
| RS (1) | RS47804A (de) |
| SV (1) | SV2003001422A (de) |
| TW (1) | TW200300685A (de) |
| WO (1) | WO2003048106A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2854399B1 (fr) * | 2003-04-30 | 2006-11-17 | Aventis Pharma Sa | 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation |
| EP1598353A1 (de) * | 2004-05-17 | 2005-11-23 | Boehringer Ingelheim International GmbH | Pyrrolobenzimidazolone und ihre Verwendung als als antiproliferative Mittel |
| WO2017103637A1 (en) | 2015-12-18 | 2017-06-22 | Blirt S.A. | Diphenylpropane compounds and their cytotoxic activity |
| KR102636496B1 (ko) | 2018-09-14 | 2024-02-15 | 삼성전자주식회사 | 통신 장치 및 이를 포함하는 전자 장치 |
| CN109467549B (zh) * | 2018-12-07 | 2021-02-09 | 中国药科大学 | 喹啉取代查尔酮类化合物、其制备方法及用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4904697A (en) * | 1987-04-09 | 1990-02-27 | Merrell Dow Pharmaceuticals Inc. | Controlling the growth of certain tumor tissue with chalcone derivatives |
| JPH08277242A (ja) * | 1995-02-08 | 1996-10-22 | Kyowa Hakko Kogyo Co Ltd | プロペノン誘導体 |
| BR9607708A (pt) * | 1995-12-01 | 1998-01-13 | Kyowa Hakko Kogyo Kk | Derivado de propenona |
| WO1999000114A2 (en) * | 1997-06-26 | 1999-01-07 | Statens Serum Institut | Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones |
-
2002
- 2002-11-21 PE PE2002001118A patent/PE20030758A1/es not_active Application Discontinuation
- 2002-11-22 PA PA20028558501A patent/PA8558501A1/es unknown
- 2002-11-26 TW TW091134346A patent/TW200300685A/zh unknown
- 2002-11-29 AR ARP020104618A patent/AR037479A1/es unknown
- 2002-12-02 SV SV2002001422A patent/SV2003001422A/es not_active Application Discontinuation
- 2002-12-03 MX MXPA04005226A patent/MXPA04005226A/es unknown
- 2002-12-03 HR HR20040508A patent/HRP20040508A2/hr not_active Application Discontinuation
- 2002-12-03 RS YU47804A patent/RS47804A/sr unknown
- 2002-12-03 EP EP02804242A patent/EP1453790A2/de not_active Withdrawn
- 2002-12-03 NZ NZ533224A patent/NZ533224A/xx unknown
- 2002-12-03 AU AU2002365644A patent/AU2002365644A1/en not_active Abandoned
- 2002-12-03 IL IL16222302A patent/IL162223A0/xx unknown
- 2002-12-03 CN CNA028268601A patent/CN1612856A/zh active Pending
- 2002-12-03 KR KR1020047008656A patent/KR20050044712A/ko not_active Withdrawn
- 2002-12-03 JP JP2003549299A patent/JP2005531494A/ja not_active Abandoned
- 2002-12-03 HU HU0500100A patent/HUP0500100A2/hu unknown
- 2002-12-03 EA EA200400764A patent/EA006803B1/ru not_active IP Right Cessation
- 2002-12-03 WO PCT/FR2002/004143 patent/WO2003048106A2/fr not_active Ceased
- 2002-12-03 CA CA002469193A patent/CA2469193A1/fr not_active Abandoned
- 2002-12-03 BR BR0214694-0A patent/BR0214694A/pt not_active IP Right Cessation
- 2002-12-03 PL PL02370676A patent/PL370676A1/xx unknown
-
2004
- 2004-06-01 MA MA27708A patent/MA27351A1/fr unknown
- 2004-06-03 CO CO04052091A patent/CO5580759A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050044712A (ko) | 2005-05-12 |
| AR037479A1 (es) | 2004-11-10 |
| SV2003001422A (es) | 2003-07-10 |
| IL162223A0 (en) | 2005-11-20 |
| NZ533224A (en) | 2006-03-31 |
| JP2005531494A (ja) | 2005-10-20 |
| PE20030758A1 (es) | 2003-10-07 |
| WO2003048106A3 (fr) | 2004-03-25 |
| PL370676A1 (en) | 2005-05-30 |
| HUP0500100A2 (hu) | 2005-05-30 |
| CA2469193A1 (fr) | 2003-06-12 |
| BR0214694A (pt) | 2004-12-14 |
| AU2002365644A1 (en) | 2003-06-17 |
| CN1612856A (zh) | 2005-05-04 |
| MXPA04005226A (es) | 2004-10-11 |
| TW200300685A (en) | 2003-06-16 |
| CO5580759A2 (es) | 2005-11-30 |
| WO2003048106A2 (fr) | 2003-06-12 |
| EA200400764A1 (ru) | 2004-12-30 |
| EP1453790A2 (de) | 2004-09-08 |
| MA27351A1 (fr) | 2005-06-01 |
| PA8558501A1 (es) | 2003-09-05 |
| EA006803B1 (ru) | 2006-04-28 |
| HRP20040508A2 (en) | 2005-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102642823B1 (ko) | 모발 성장을 조절하기 위한 조성물 및 방법 | |
| IL284397B2 (en) | Compositions and methods for regulating hair growth | |
| JPH06506445A (ja) | ヒドロキサム酸誘導体、それらの製造方法及び用途 | |
| CA2287565A1 (fr) | Derives d'amino-acides inhibiteurs des metalloproteases de la matrice extracellulaire et de la liberation du tnf .alpha. | |
| EP1773835B1 (de) | Pyrido-pyrimidinderivate, deren herstellung und therapeutische verwendung zur behandlung von krebs | |
| JP4780885B2 (ja) | 正常細胞を化学療法剤の細胞毒性から保護するための方法 | |
| CN108218800B (zh) | 1,2,3-三氮唑类氨肽酶n抑制剂及其制备方法和应用 | |
| HRP20040508A2 (en) | 1,3-diarylprop-2-en-1-ones, compositions containing the same and use thereof | |
| US20030153611A1 (en) | 1,3-Diarylprop-2-en-1-ones, compositions containing them and use thereof | |
| CN101544669B (zh) | 一种含氨基膦酸酯的苯基氰基丙烯酸酯衍生物及其制备方法和用途 | |
| CN102241665B (zh) | 4-(4,5-二甲氧羰基-1,3-二硫戊环-2-基)苯甲酰-l-氨基酸苄酯及其合成方法和应用 | |
| ES2272816T3 (es) | Aril-cicloalcanos sustituidos y su utilizacion como agentes anticancerigenos. | |
| CN108047105A (zh) | 3-/4-酯基取代苯甲醛缩氨基硫脲衍生物及其制备与应用 | |
| US20040229931A1 (en) | 1-Aryl-3-(indol-5-yl) prop-2-en-1-ones, compositions containing them and use | |
| CN101906069A (zh) | (s)-2-取代-(3’-乙酰基-2’-吡啶酮-1’-基)乙酸及其制备方法和应用 | |
| CN104892724B (zh) | 二肽小分子修饰的杂N稳定的Fischer卡宾化合物及其制备方法 | |
| CN101597276A (zh) | N-(α,β-二巯基-β-羧基丙酰基)-氨基酸的丙叉衍生物及其合成方法和应用 | |
| CN116730969B (zh) | 一种β-拉帕醌-氨基酸缀合物及其制备方法和应用 | |
| KR20040108787A (ko) | 중추 신경계 장애의 치료에 사용하기 위한 실질적으로순수한 고체 형태의 3-인돌릴피브르산의 에놀 토토머 | |
| WO1993013049A1 (fr) | Emploi de l'effet immunoactivant de 3-naphthyloxy-2-hydroxy-propylamines, interessant specialement pour l'immunite cellulaire, par exemple contre infections virales | |
| JP2006525291A (ja) | 1−アリール−3−(インドール−5−イル)プロパ−2−エン−1−オン、該化合物を含む組成物、及びそれらの使用 | |
| CN106431855A (zh) | 卤素或含氮基团取代的联苄类似物及其制备方法和用途 | |
| NZ759233B2 (en) | Compositions and methods for modulating hair growth | |
| CA2297944A1 (en) | The groups with anticancer activity and the method of making their derivatives | |
| KR20090032373A (ko) | 3-클로로-5-치환-퀴녹살린-2-아민 유도체 및 약제학적으로허용 가능한 그의 염, 그의 제조방법 및 그를 유효성분으로함유하는 spc 수용체 활성으로 유발되는 염증관련 질환치료제 |